|
|
Document No.: WI-P-002-A-V0 | CONTROLLED COPY Do not copy or remove |
| Parent Document: SOP-P-002, Sections 5.2–5.4, 5.7 | Version: V0 | ||
| Applies to: Medical Technologists, Phlebotomists, and Nursing Personnel | Effective Date: MM-DD-YYYY | Supersedes: None | ||
Phlebotomy Section & Clinical Wards | Standard Venous Blood Collection Sequence
| Order | Stopper Color & Type | Additive & Action | Laboratory Section & Tests | Inversions |
|---|---|---|---|---|
| 1st |
Blood Culture
SPS / Broth Bottle |
Sodium Polyanethol Sulfonate (SPS); preserves micro-organisms | Microbiology / Referral: Blood cultures, sterile body fluids |
8–10× Gentle mix |
| 2nd |
Light Blue
Sodium Citrate 3.2% |
0.109 M / 3.2% Sodium Citrate; binds calcium (1:9 ratio) | Coagulation / Hematology: Prothrombin Time (PT), APTT |
3–4× Strict 1:9 fill |
| 3rd |
Plain Red (no gel)
Silica clot activator Gold SST
Clot activator + gel separator |
Silica clot activator; plain red has no gel, Gold SST has polymer barrier gel | Clinical Chemistry & Serology: FBS, BUN, Creat, Lipids, LFTs, Dengue |
5× Clot 20–30 min |
| 4th |
Green
Lithium Heparin |
Lithium Heparin; inhibits thrombin formation | STAT Chemistry: Electrolytes, STAT troponin, enzymes |
8–10× Gentle mix |
| 5th |
Lavender
K2EDTA Vacuum |
Dipotassium EDTA (1.5–2.2 mg/mL); chelates calcium | Hematology: CBC, 5-Part Diff, PBS Smear, Retic, Blood Typing |
8–10× No clots allowed |
| 6th |
Gray
Fluoride / Oxalate |
Sodium Fluoride (glycolytic inhibitor) + Potassium Oxalate | Confirmatory Glucose: Fasting Blood Sugar, OGTT curves |
8–10× Inhibits enolase |
Note: For citrate (light-blue) draws via winged/butterfly sets, draw a discard tube first.
| Prepared by: Chief Medical Technologist Signature: _______________________ Date: ________ |
Reviewed by: Pathologist Signature: _______________________ Date: ________ |
Approved by: Hospital Director Signature: _______________________ Date: ________ |